Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial. Veröffentlicht vonadmin 27. Juli 2020 Hopfinger G, NГ¶sslinger T, Lang A, Linkesch W, Melchardt T, Weiss L, Egle A, Greil R. http://www.ncbi.nlm.nih.gov/pubmed/24441915